ライフサイエンスコーパス: prematurity

1 ronchopulmonary dysplasia, or retinopathy of prematurity).

2 ss) at 22 to 26 months of age, corrected for prematurity.

3 ent at 22 to 26 months of age, corrected for prematurity.

4 es such as low birth weight, stillbirth, and prematurity.

5 atal infections, and chronic lung disease of prematurity.

6 onic lung disease, and severe retinopathy of prematurity.

7 adult cognitive impairments associated with prematurity.

8 t and/or treat asthma development related to prematurity.

9 ng enterocolitis, a severe illness linked to prematurity.

10 prevent hypoalveolarization associated with prematurity.

11 r a high proportion of long-term sequelae of prematurity.

12 isease, and stage 3 or higher retinopathy of prematurity.

13 mediate delivery is associated with risks of prematurity.

14 ere complicated by severe polyhydramnios and prematurity.

15 sion positively correlated with the level of prematurity.

16 or language delay, and severe retinopathy of prematurity.

17 r leukomalacia, and/or severe retinopathy of prematurity.

18 ing enterocolitis, and severe retinopathy of prematurity.

19 sociated with significantly elevated odds of prematurity.

20 associated with infertility, miscarriage and prematurity.

21 at is representative of human retinopathy of prematurity.

22 nes, retinal detachments, and retinopathy of prematurity.

23 nal age, suffer the greatest consequences of prematurity.

24 ams in premature infants with retinopathy of prematurity.

25 on glaucoma (NTG) when there is a history of prematurity.

26 ring them for a life free of the sequelae of prematurity.

27 incidence did not differ by HIV exposure or prematurity.

28 intraocular pressure (IOP), and sequelae of prematurity.

29 ount equal or greater than the degree of PHC prematurity.

30 tive diabetic retinopathy and retinopathy of prematurity.

31 parate effects of fetal growth from those of prematurity.

32 in bronchopulmonary dysplasia, a disease of prematurity.

33 ortical folding to be a permanent feature of prematurity.

34 tive retinopathies, including retinopathy of prematurity.

35 than a 2-year interval had higher risks for prematurity (11.8% vs 17.2%; RR, 1.48; 95% CI, 1.00-2.19

36 c ocular injury (15 [22.1%]), retinopathy of prematurity (12 [17.6%]), and endophthalmitis (6 [8.8%])

37 ital malformations (18.9%), complications of prematurity (14.2%), human immunodeficiency virus/AIDS (

38 a severe condition called encephalopathy of prematurity(3).

39 ble odds ratio [OR] 4.62, 95% CI 2.82-7.55), prematurity (4.33, 2.47-7.58), sickle cell disease (3.46

40 ng underlying CoD included "complications of prematurity" (52.9%), "complications of intrapartum even

41 Among neonatal deaths with underlying prematurity, 60% were precipitated by other infectious c

42 the polymorphism could influence the risk of prematurity among human fetuses of mothers colonized wit

43 hemorrhage (IVH) is a major complication of prematurity and a large number of survivors with IVH dev

44 utations caused X-linked polyhydramnios with prematurity and a severe but transient form of antenatal

45 onsiveness in PNPO deficiency is affected by prematurity and age at the time of the therapeutic trial

46 esults, we showed that, when controlling for prematurity and analgesics, supportive experiences (e.g.

47 there was no significant association between prematurity and asthma in nonatopic children.

48 children share a disproportionate burden of prematurity and asthma in the United States.

49 there was a significant interaction between prematurity and atopy on asthma (P = .006).

50 1997" birth cohort, adjusted associations of prematurity and birth weight with forced expiratory volu

51 Infants with a history of prematurity and bronchopulmonary dysplasia have a high r

52 Although prematurity and cardiopulmonary disease are risk factors

53 RSV LRTI, almost exclusively associated with prematurity and cardiopulmonary diseases in industrializ

54 Little is known about prematurity and childhood asthma in Puerto Rican subject

55 and investigated its link with the degree of prematurity and cognition.

56 on of ocular diseases such as retinopathy of prematurity and diabetic retinopathy, overgrowth of reti

57 e tissue revascularization in retinopathy of prematurity and in diabetic patients.

58 radiologically in patients with a history of prematurity and is associated with visual field (VF) def

59 are at risk of developing encephalopathy of prematurity and long-term neurodevelopmental delay.

60 Odds of stillbirth, prematurity and low birth weight, frequency and length o

61 anomalies cryptorchidism and hypospadias are prematurity and low birth weight.

62 icant factors associated with mortality were prematurity and low birthweight.

63 We aimed to determine if prematurity and lower birth weight are associated with p

64 Exclusion criteria included prematurity and pre-existing neurologic, genetic, metabo

65 cally contributed to the association between prematurity and reduced adult IQ (two-path mediation), i

66 l health challenges strongly associated with prematurity and reduced fetal growth, an issue of furthe

67 5 years of age and to evaluate the impact of prematurity and ROP.

68 the best quartile for severe retinopathy of prematurity and severe intraventricular hemorrhage, and

69 nsity, appropriate to age at scan, degree of prematurity and sex.

70 Maternal asthma was associated with prematurity and small for gestational age.

71 or diagnosis and treatment of retinopathy of prematurity and to provide interpretation and perspectiv

72 Although prematurity and underlying medical conditions are known

73 relationship of cupping, field defects, and prematurity and who may diagnose manifest or suspected n

74 ut to distinguish between confounders (e.g., prematurity) and mediators (e.g., use of pacifier).

75 ttle of how brain maturation at birth (i.e., prematurity) and quality of early-life experiences (e.g.

76 nts of the primary outcome, complications of prematurity, and growth.

77 ronchopulmonary dysplasia and retinopathy of prematurity, and may form a bridge between two currently

78 ng enterocolitis, aspiration, retinopathy of prematurity, and perinatal mortality.

79 l age, birth weight, stage of retinopathy at prematurity, and presence of pre-plus or plus disease) v

80 a, necrotizing enterocolitis, retinopathy of prematurity, and severe intraventricular hemorrhage.

81 in quality of life, psychological distress, prematurity, and small-for-gestational-age, also were co

82 olitis, or stage 3 or greater retinopathy of prematurity; and severe neonatal brain injury, defined a

83 95% CI, 0.63-1.01), or severe retinopathy of prematurity (AOR, 0.78; 95% CI, 0.56-1.10).

84 -2.21), and stage 3 or higher retinopathy of prematurity (aOR, 1.18; 95% CI, 1.06-1.32).

85 95% CI, 0.78-2.39) or severe retinopathy of prematurity (aOR, 1.61; 95% CI, 0.85-3.06).

86 The 2 hallmarks of brain pathologies of prematurity are a restricted gestational window of vulne

87 Furthermore, both gyrification and prematurity are tightly linked with cognitive performanc

88 Goals for retinopathy of prematurity are to optimize prenatal and perinatal care,

89 We identified prematurity as a new strong risk factor for influenza-re

90 ncy, perinatal infections and retinopathy of prematurity as well as specialist pediatric eye care fac

91 % (58/81) of neonates with "complications of prematurity" as the underlying cause.

92 ions were associated with both the degree of prematurity, as assessed via gestational age and birth w

93 lytical framework to show that the degree of prematurity at birth determines the extent to which brai

94 cutive premature infants with retinopathy of prematurity at the Oxford Eye Hospital, Oxford, England,

95 eflect biases from restricting the cohort to prematurity, because prematurity is an outcome of preecl

96 < 0.05, corrected), independent of degree of prematurity, bronchopulmonary dysplasia and postnatal se

97 ith more neonatal unit admissions related to prematurity but no indicators of greater neonatal morbid

98 tic neuropathy, nystagmus, or retinopathy of prematurity) by ICD-9 codes in typically developing (TD)

99 associated with baseline impaired function, prematurity, cancer, respiratory failure etiology, venti

100 d a case of a baby without history of ROP or prematurity (Case 4).

101 en's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) model uses birth weight (BW), ges

102 en's Hospital of Philadelphia Retinopathy of Prematurity (CHOP-ROP) postnatal weight gain predictive

103 age, weight, prior cardiothoracic operation, prematurity, chromosomal abnormalities, syndromes, nonca

104 e to common lung, eye, and brain diseases of prematurity classically associated with hypoxic insults.

105 Prematurity complications are a major driver of stillbir

106 data from the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) and Early Treatment for Retinopat

107 he overall goal is to clarify retinopathy of prematurity currently and formulate questions to optimiz

108 Patients with extreme prematurity, cyanotic congenital heart disease, pulmonar

109 so review the applications to retinopathy of prematurity, diabetic retinopathy, age-related macular d

110 cular eye diseases, including retinopathy of prematurity, diabetic retinopathy, and age-related macul

111 reatening diseases, including retinopathy of prematurity, diabetic retinopathy, and age-related macul

112 Caffeine therapy for apnea of prematurity did not significantly reduce the combined ra

113 Worldwide, retinopathy of prematurity differs and, in emerging countries, has feat

114 hes to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study and to evaluate their potentia

115 hes to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study telemedicine system of remote

116 hes to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) study was conducted from May 1, 2011

117 the Evaluation of Acute-Phase Retinopathy of Prematurity (e-ROP) study.

118 t across cortical areas in the brain conveys prematurity effects on adult IQ.

119 al candidates for prognosis and treatment of prematurity effects.

120 erlying pathophysiology of encephalopathy of prematurity employ significant insults to generate gross

121 Encephalopathy of prematurity encompasses the multifaceted diffuse brain i

122 -ROP) and Early Treatment for Retinopathy of Prematurity (ETROP) trials and the primary data from the

123 ced in the United States when retinopathy of prematurity first manifested.

124 arly-onset NTHi increased exponentially with prematurity, from 0.9 per 100 000 (95% confidence interv

125 and the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study (a multicenter retrospective c

126 from the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.

127 st 2 risk factors for neurotoxicity, such as prematurity, glucose-6-phosphate dehydrogenase deficienc

128 itive performance, indicating a link between prematurity, gyrification, and cognitive performance.

129 Retinopathy of prematurity has evolved from affecting infants approxima

130 ary dysplasia (BPD), the main consequence of prematurity, has a significant heritability, but little

131 Advantages of caffeine for apnea of prematurity have prompted clinicians to use it prophylac

132 /disability at 18 to 24 months corrected for prematurity; however, this outcome has not been reported

133 dvancement was equal or greater than the PHC prematurity in 26/29 AVRTs and none of the AVNRTs (90% s

134 lis are associated with late miscarriage and prematurity in high-risk pregnancies.

135 nificant decrease in rates of retinopathy of prematurity in our post-intervention group was found.

136 young adults who were born at any degree of prematurity in the Preterm Birth and Early Life Programm

137 There was no association with retinopathy of prematurity in the preterm group, which suggests that be

138 rdings and gestational age or retinopathy of prematurity in the preterm group.

139 Several clinical complications of prematurity including necrotizing enterocolitis, systemi

140 infants, but the long-term complications of prematurity, including bronchopulmonary dysplasia (BPD),

141 Prematurity, independent of medical complications, leads

142 en the groups in the rates of retinopathy of prematurity, intracranial hemorrhage, sepsis, necrotizin

143 Apnea of prematurity is a common condition that is usually treate

144 Retinopathy of prematurity is a leading cause of childhood blindness wo

145 Extreme prematurity is a major risk factor for perinatal and neo

146 Retinopathy of prematurity is a sight-threatening complication of prema

147 stricting the cohort to prematurity, because prematurity is an outcome of preeclampsia.

148 We sought to examine whether prematurity is associated with asthma in Puerto Rican ch

149 Using a mouse model where encephalopathy of prematurity is induced by systemic interleukin-1beta adm

150 Retinopathy of prematurity is located asymmetrically around the optic d

151 In the developed world, extreme prematurity is the leading cause of neonatal mortality a

152 Prematurity is the leading cause of perinatal morbidity

153 nd adverse pregnancy outcomes (fetal demise, prematurity, low birth weight and congenital anomaly) in

154 of residence, urban/rural area of domicile, prematurity, low birth weight, and mother's age.

155 , proportions of major congenital anomalies, prematurity, low birth weight, and small size for gestat

156 nd adverse pregnancy outcomes (fetal demise, prematurity, low birth weight, congenital anomaly) in pr

157 d the influence of ZIKV on the prevalence of prematurity, low birth weight, small-for-gestational-age

158 cy does not appear to influence the risks of prematurity, low birth weight, small-for-gestational-age

159 e was not associated with increased risks of prematurity, low birth weight, small-for-gestational-age

160 The incidence of prematurity (<37 weeks' gestation) was also similar (chi

161 Maternal age, gestational age, prematurity (<37 weeks' gestation), type of ARV prophyla

162 Prematurity might explain, in part, the high prevalence

163 natal ultrasonography, severe retinopathy of prematurity, necrotizing enterocolitis, or late-onset se

164 y for respiratory distress syndrome (RDS) of prematurity needs to be further elucidated by large, ran

165 The primary outcomes were prematurity, neonatal intensive care unit (NICU) admissi

166 , bronchopulmonary dysplasia, retinopathy of prematurity, neurodevelopmental outcomes, or hearing los

167 years were associated with higher risks for prematurity, NICU admission, and SGA status compared wit

168 percentile, gestational age, retinopathy of prematurity occurrence, maternal age at childbirth, moth

169 wo major perceived risk factors for BPD were prematurity of <28 weeks and high oxygen requirements.

170 28-70 ms) and the advancement less than the prematurity of the PHC (mean, 32 ms; range, 18-54 ms).

171 The mean prematurity of the PHC required to perturb AVNRT was 48

172 circuit but only by a quantity less than the prematurity of the PHC.

173 nt gyrification contributes to the impact of prematurity on adult cognitive performance.

174 that atopy modifies the estimated effect of prematurity on asthma in Puerto Rican children.

175 by plurality, and the independent effect of prematurity on childhood costs.

176 ferent PVC locations and coupling intervals (prematurity) on LV regional mechanics and global functio

177 LV dyssynchrony cannot be attributed to prematurity or abnormal ventricular activation alone, bu

178 Alas, surviving early hazards, like prematurity or infectious disease, does not guarantee th

179 ration, diabetic retinopathy, retinopathy of prematurity, or as a complication following cataract sur

180 nces in chronic lung disease, retinopathy of prematurity, or NDI among survivors.

181 Two young patients with a history of prematurity presented with enlarged cup-to-disc ratio an

182 blinding eye diseases such as retinopathy of prematurity, proliferative diabetic retinopathy, and wet

183 uding sofas), exposure to tobacco smoke, and prematurity; protective factors include breastfeeding, p

184 n enrolled in the CAP (Caffeine for Apnea of Prematurity) randomized controlled trial and assessed at

185 e found in the congenital malformation rate, prematurity rate, and Apgar scores.

186 Retinopathy of prematurity recurred in 3 (14%) of 22 IVB-treated eyes a

187 On the contrary, prematurity reduced the risk of its use.

188 Caffeine citrate therapy for apnea of prematurity reduces the rates of bronchopulmonary dyspla

189 n injury topography, severity of injury, and prematurity-related clinical complications.

190 2 is a modifier of susceptibility to PTB and prematurity-related morbidity and mortality in the offsp

191 cacy of DNAC in preventing preterm birth and prematurity-related outcomes.

192 lar results were obtained in our analysis of prematurity requiring admission to the neonatal intensiv

193 arteriosus requiring surgery, retinopathy of prematurity requiring surgery, necrotizing enterocolitis

194 ndidemia, bacteremia, very low birth weight, prematurity, respiratory disorders, and ROP.

195 t in the endophthalmitis population included prematurity, respiratory disorders, perinatal infections

196 Cases involving retinopathy of prematurity resulted in the highest payments to plaintif

197 man premature infants.SIGNIFICANCE STATEMENT Prematurity results in developmental delays and neurobeh

198 ings are consistent with the assumption that prematurity results in long-term detrimental effects on

199 nfarcts, obstructive sleep apneas, apneas of prematurity, Rett syndrome, and sudden infant death synd

200 as those who were treated for retinopathy of prematurity (ROP) (ROP-Tx group); those with spontaneous

201 Retinopathy of prematurity (ROP) affects only premature infants, but as

202 pulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) are two debilitating disorders that de

203 bevacizumab (IVB) for type 1 retinopathy of prematurity (ROP) are uncertain.

204 are known predictors of worse retinopathy of prematurity (ROP) but the role of prenatal growth patter

205 diagnosis of plus disease in retinopathy of prematurity (ROP) by experts.

206 rove diagnostic competency in retinopathy of prematurity (ROP) by ophthalmologists-in-training in Mex

207 l evaluation is necessary for retinopathy of prematurity (ROP) cases.

208 Retinopathy of prematurity (ROP) causes 100,000 new cases of childhood

209 ) agents for the treatment of retinopathy of prematurity (ROP) compared with laser photocoagulation t

210 ge grading of fellow eyes for retinopathy of prematurity (ROP) features (stage, zone and plus disease

211 Telemedicine in retinopathy of prematurity (ROP) has the potential for delivering timel

212 ents for potentially blinding retinopathy of prematurity (ROP) have been introduced, the importance o

213 ection of treatment-requiring retinopathy of prematurity (ROP) involves serial eye examinations.

214 Retinopathy of prematurity (ROP) is a leading cause of childhood blindn

215 Severe Retinopathy of Prematurity (ROP) is a serious vasoproliferative disorde

216 Retinopathy of prematurity (ROP) is a vision-threatening disease in pre

217 Retinopathy of prematurity (ROP) is characterized by an initial retinal

218 Retinopathy of prematurity (ROP) is one of the targets for early detect

219 Retinopathy of prematurity (ROP) is the leading cause of childhood blin

220 ment/blindness as a result of retinopathy of prematurity (ROP) may rise.

221 e miR-17 family in the murine retinopathy of prematurity (ROP) model, whereby Vegfa expression is hig

222 born prematurely who develop retinopathy of prematurity (ROP) often develop myopia, and those who re

223 diabetic retinopathie (DR), retinopathie of prematurity (ROP) or the retinal vein occlusion (RVO) ar

224 ncluding 8 cases of bilateral retinopathy of prematurity (ROP) received RLT.

225 efinitions of plus disease in retinopathy of prematurity (ROP) reference arterial tortuosity and veno

226 infants needing treatment for retinopathy of prematurity (ROP) requires repeated examinations of at-r

227 mologic equipment used during retinopathy of prematurity (ROP) screening.

228 ne preterm infants undergoing retinopathy of prematurity (ROP) screenings.

229 Treatment of retinopathy of prematurity (ROP) stage 3 plus with bevacizumab is still

230 ctor (VEGF) in a patient with retinopathy of prematurity (ROP) treated with ranibizumab (Case 1) and

231 clinicians using an automated retinopathy of prematurity (ROP) vascular severity score.

232 Screening for retinopathy of prematurity (ROP) was performed in the neonatal period.

233 More severe stages of retinopathy of prematurity (ROP) were found among CMV-infected infants

234 the presence and severity of retinopathy of prematurity (ROP) were investigated by univariate and mu

235 ously diagnosed with neonatal retinopathy of prematurity (ROP), 38% of eyes (84) had ROP not deemed t

236 nter Trial of Cryotherapy for Retinopathy of Prematurity (ROP), 4099 infants weighing less than 1251

237 Patients with PDR, retinopathy of prematurity (ROP), and wet age-related macular degenerat

238 omponent of clinical care for retinopathy of prematurity (ROP), but little information exists regardi

239 easingly used to treat type 1 retinopathy of prematurity (ROP), but there remain concerns about syste

240 linding retinopathies such as retinopathy of prematurity (ROP), diabetic retinopathy (DR) and retinal

241 retinopathy (OIR) resembling retinopathy of prematurity (ROP), loss of Casp-8 in ECs was beneficial,

242 Retinopathy of prematurity (ROP), the most common cause of blindness in

243 Retinopathy of prematurity (ROP), the primary cause of blindness in chi

244 actor agents for treatment of retinopathy of prematurity (ROP), there are few data on their ocular ef

245 pulmonary dysplasia (BPD) and retinopathy of prematurity (ROP), with cortical maturational changes in

246 omy (LSV) surgery in advanced retinopathy of prematurity (ROP).

247 to predict the risk of severe retinopathy of prematurity (ROP).

248 s in children with or without retinopathy of prematurity (ROP).

249 ategies for the management of retinopathy of prematurity (ROP).

250 laser photoablation in type 1 retinopathy of prematurity (ROP).

251 ions between preeclampsia and retinopathy of prematurity (ROP).

252 ated with treatment-requiring retinopathy of prematurity (ROP).

253 ctors for treatment-demanding retinopathy of prematurity (ROP).

254 rs, perinatal infections, and retinopathy of prematurity (ROP).

255 ages from infants at risk for retinopathy of prematurity (ROP).

256 ffective for the treatment of retinopathy of prematurity (ROP).

257 itively affect the outcome of retinopathy of prematurity (ROP).

258 an 3 days after birth, severe retinopathy of prematurity, severe intraventricular hemorrhage, necroti

259 t related to clinical factors including age, prematurity, sex, intrauterine complications, and postna

260 pression are implicated, including apnoea of prematurity, sleep disordered breathing and congestive h

261 o develop a representative encephalopathy of prematurity small animal model only dependent on preterm

262 is compromised (e.g., sleep apnea, apnea of prematurity, spinal injury, or motor neuron disease).

263 a, necrotizing enterocolitis, retinopathy of prematurity stage 3-5, or severe bronchopulmonary dyspla

264 e bronchopulmonary dysplasia, retinopathy of prematurity (stage 3 or higher), or necrotizing enteroco

265 spective Postnatal Growth and Retinopathy of Prematurity Study (G-ROP) 1 study (2006-2012) and the pr

266 hes to Evaluating Acute-Phase Retinopathy of Prematurity study, conducted from May 2011 to October 20

267 hes to Evaluating Acute-Phase Retinopathy of Prematurity Study.

268 after the Early Treatment for Retinopathy of Prematurity Study.

269 he increasing number of survivors of extreme prematurity suffering the most severe forms of bronchopu

270 4, the gene encoding FATP4, cause ichthyosis prematurity syndrome (IPS), characterized by premature b

271 FATP4 (SLC27A4) mutations cause ichthyosis prematurity syndrome, a nonlethal disorder.

272 y dysplasia (BPD), a chronic lung disease of prematurity that often leads to sequelae in adult surviv

273 When controlling for very low BW and prematurity, the presence of preplus disease, stage 2 RO

274 re the most common organisms associated with prematurity, their effects on the maternal and fetal imm

275 e evidence of a relationship between BPA and prematurity, though further research may be warranted gi

276 ed, placebo-controlled Caffeine for Apnea of Prematurity trial between October 11, 1999, and October

277 tivity for Early Treatment of Retinopathy of Prematurity type 1 ROP and potential reduction in the nu

278 In the absence of prematurity, UPI increased angiogenic factors in associa

279 ing but not limited to epigenetic variation, prematurity, vitamin D level, diet, and stress.

280 Notably, more extreme prematurity was associated with increased functional con

281 Prematurity was correlated with a worse cognitive outcom

282 Prematurity was defined by parental report for our prima

283 usted probability of death or retinopathy of prematurity was highest among infants born at hospitals

284 e or placebo until drug therapy for apnea of prematurity was no longer needed.

285 In the absence of treated ROP, prematurity was not associated with disturbed retinal st

286 To date the exclusive effect of prematurity was only studied in a non-human primate mode

287 85 (26.0%); and treatment for retinopathy of prematurity was required in 41/472 (8.7%) vs 38/492 (7.7

288 y (UPI) increases severity of retinopathy of prematurity, we developed a composite rat model of UPI a

289 6%) with GA </= 32 weeks with retinopathy of prematurity were affected by strabismus.

290 ions with gestational age and retinopathy of prematurity were examined.

291 lung function at 6 weeks, infant growth, and prematurity were other independent predictors of lung fu

292 l outcomes, hearing loss, and retinopathy of prematurity were similar between the 2 groups.

293 to lots of factors as preterm subtype, late prematurity, which account for the vast majority of case

294 Apnea of prematurity, which is prevalent among infants born at le

295 modelling showed that age, cause of PAH, ex-prematurity, WHO functional class, trisomy 21, and time

296 rdiovascular development, and retinopathy of prematurity with lung development.

297 lower birth weight, especially in boys, and prematurity with poorer lung function at 17.5 years were

298 e RSV burden extends across cost domains and prematurity, with the greatest burden incurred by the se

299 athophysiologic risk factors, retinopathy of prematurity worldwide, basic and clinical science partic

300 sed that the extreme environmental stress of prematurity would promote neuroanatomic abnormality in i